I want to know about...

THE CITY RECORD

4560

4. Urban Development Action Area UDAA designation, Urban Development Action Area Project UDAAP designation, and disposition of Lot 1, comprising 146,105 sq. ft.
5. Approval to modify a specified community facility use for the disposition of Lot 10, to permit and continue general community facility uses The requested actions would facilitate a phased, mixed-use complex involving the construction of two new 14- and 18-story buildings, the enlargement of two existing ones, and the replacement of a 200-bed homeless shelter. The resulting development would yield 553 units of affordable and senior housing augmented by community facility uses and light retail. The project would establish connections among four privately-owned residences on the site and ensure the continued operation of the Greenpoint Renaissance Center.

TUESDAY, JULY 20, 2021

Written comments will also be accepted until 11:59 P.M., one week before the date of vote. Such written testimony may be submitted, at the hearing, or through the CPC Comments form that is accessible through the above webpage.
Please inform the Department of City Planning if you need a reasonable accommodation, such as a sign language interpreter, in order to participate in the meeting. The submission of testimony, verbal or written, in a language other than English, will be accepted, and real time interpretation services will be provided based on available resources. Requests for a reasonable accommodation or foreign language assistance during the meeting should be emailed, to AccessibilityInfo@
planning.nyc.gov, or made by calling 212-720-3508. Requests must be submitted at least five business days before the meeting.

2 824 Metropolitan Avenue 200314 ZMK, 200315 ZRK
An application by 824 Metropolitan Avenue Owner, LLC, pursuant to sections 197-c and 201 of the New York City Charter for land use actions affecting an 18,835 square foot sq. ft. property near the intersection of Bushwick and Metropolitan avenues. The proposed zoning map amendment would change portions of the project area from C8-2 and R6B districts to R6B/C2-4, R7A and R7A/C2-4. The proposed zoning text amendment would designate an MIH area coterminous with the project area. The requested actions are intended to facilitate an eight-story, 34,000 sq. ft. development with 36 dwelling units, and 7,000 sq. ft. of commercial uses in Brooklyn CD 1. Approximately 11
units would be affordable to households earning an average 80 percent of Area Median Income AMI, pursuant to MIH Option 2.

CD 8
C 210351 ZMM
IN THE MATTER OF an application submitted by New York Blood Center, Inc., pursuant to Sections 197-c and 201 of the New York City Charter, for an amendment of the Zoning Map, Section No. 8c:
1.

Accessibility questions: Nathan Sherfinski, 718 802-3857, nathan.
sherfinski@brooklynbp.nyc.gov, by: Tuesday, July 20, 2021, 5:00 P.M

changing from an R8B District to a C2-7 District property, bounded by East 67th Street, a line 325 feet easterly of Second Avenue, East 66th Street and a line 100 feet easterly of Second Avenue; and
2.

changing from a C1-9 District to a C2-8 District property, bounded by East 67th Street, a line 100 feet easterly of Second Avenue, East 66th Street, Second Avenue, East 66th Street, and a line 100 feet westerly of Second Avenue;

jy16-26

CITY PLANNING COMMISSION
PUBLIC HEARINGS

In light of the Governors announcement on June 24, 2021, of the end of the State-Declared State of Emergency, and in support of the Citys continued efforts to contain the spread of COVID-19, the City Planning Commission, will hold a public hearing accessible both in person and remotely.
The public hearing will be held on Thursday, July 29, 2021, starting at 10:00 A.M. Eastern Daylight Time. The public hearing will be held in person in the NYC City Planning Commission Hearing Room, Lower Concourse, 120 Broadway, New York, NY. Masks are required to be worn to enter the building and during the hearing.
The meeting will be live streamed through Department of City Plannings DCPs website and accessible from the following webpage, which contains specific instructions on how to observe and participate remotely, via the teleconferencing application Zoom, as well as materials relating to the meeting: https www1.nyc.gov/site/nycengage/
events/city-planning-commission-special-public-meeting/295196/1.
Members of the public attending remotely should observe the meeting through DCPs website. Verbal testimony can be provided remotely by joining the meeting using either Zoom, or by calling the following number and entering the information listed below:
877 853 5247 US Toll-free 888 788 0099 US Toll-free 253 215 8782 US Toll Number 213 338 8477 US Toll Number Meeting ID: 618 237 7396
Press to skip the Participation ID
Password: 1

BOROUGH OF MANHATTAN
Nos. 1, 2 & 3
NEW YORK BLOOD CENTER
No. 1

as shown on a diagram for illustrative purposes only, dated April 19, 2021, and subject to the conditions of CEQR Declaration E-612.
No. 2
CD 8
N 210352 ZRM
IN THE MATTER OF an application submitted by New York Blood Center, Inc., pursuant to Section 201 of the New York City Charter, for an amendment of the Zoning Resolution of the City of New York, modifying Article VII, Chapter 4, for the purpose of allowing scientific research and development facilities in C2-7 Districts and allowing related use and bulk modifications, and modifying APPENDIX F, for the purpose of establishing a Mandatory Inclusionary Housing area.
Matter underlined is new, to be added;
Matter struck out is to be deleted;
Matter within is defined in Section 12-10;
indicates where unchanged text appears in the Zoning Resolution.
ARTICLE III
COMMERCIAL DISTRICT REGULATIONS
Chapter 2
Use Regulations
32-30
USES PERMITTED BY SPECIAL PERMIT
32-32
By the City Planning Commission In the districts indicated, the following uses are permitted by special permit of the City Planning Commission, in accordance with standards set forth in Article VII, Chapter 4, or as otherwise indicated in this Section.